Back in December 2016, Jennifer Gill et al discussed in their published Paper whether Real World Evidence could play a more prominent role in decision making. Their latest published paper RWE in Europe Paper II The use of Real World Evidence in the disease context is the second in this series of papers looking at Real World Evidence. The paper analyses the opinions of a number of key experts in pricing and reimbursement from a selection of countries across Europe.